Suspension of trading
Intellipharmaceutics International Inc. Share Price Deutsche Boerse AG
Stocks
I4AA
CA4581733090
Pharmaceuticals
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0445 EUR | -13.59% |
|
-.--% | - |
| Market Cap | 14.06L 12.23L 11.38L 10.45L 19.73L 13Cr 20.04L 1.34Cr 52.65L 6.68Cr 52.82L 51.66L 22Cr | P/E 2021 |
-0.69x | P/E 2022 | -0.82x |
|---|---|---|---|---|---|
| Enterprise Value | 36.49L 31.72L 29.52L 27.11L 51.19L 35Cr 51.98L 3.48Cr 1.37Cr 17Cr 1.37Cr 1.34Cr 58Cr | EV / Sales 2021 |
-
| EV / Sales 2022 | 70.4x |
| Free-Float |
98.24% | Yield 2021 * |
-
| Yield 2022 | - |
| 1 day | -13.59% |
| 3 years | 0.03 |  | 0.08 |
| 5 years | 0.01 | | 0.18 |
| 10 years | 0.01 | | 35 |
| Manager | Title | Age | Since |
|---|---|---|---|
Amina Odidi
DFI | Director of Finance/CFO | - | - |
| Comptroller/Controller/Auditor | - | 01/04/2007 | |
| Corporate Officer/Principal | - | 01/02/2014 |
| Director | Title | Age | Since |
|---|---|---|---|
Amina Odidi
BRD | Director/Board Member | - | 01/09/2004 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 14/02/24 | Option | Director | 1,00,000 | 0.3022% | ||
| 13/02/24 | Option | Director | 1,20,000 | 0.3626% | ||
| 13/02/24 | Option | Executive/Senior Manager | 2,00,000 | 0.6044% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -13.59% | -.--% | - | - | 33 | |
| -0.53% | -3.95% | +55.23% | +152.74% | 1,02400Cr | |
| +0.21% | -2.68% | +55.61% | +53.02% | 62TCr | |
| -2.51% | -3.25% | +32.76% | +67.76% | 44TCr | |
| +0.06% | -0.42% | +37.53% | +30.67% | 35TCr | |
| -0.14% | -0.24% | +34.41% | +39.01% | 30TCr | |
| -0.69% | -0.30% | +11.55% | +12.93% | 26TCr | |
| -7.37% | -4.40% | -2.54% | -43.87% | 21TCr | |
| -0.64% | +2.43% | +30.52% | +64.49% | 21TCr | |
| -0.82% | +0.70% | +15.96% | +71.01% | 16TCr | |
| Average | -2.60% | -1.20% | +30.11% | +49.75% | 39.71TCr | |
| Weighted average by Cap. | -0.99% | -1.93% | +39.24% | +72.95% |
| 2021 | 2022 | |
|---|---|---|
| Net sales | - | 65.73T 57.14T 53.18T 48.83T 92.21T 62.74L 93.64T 6L 2L 31.24L 2L 2L 1.05Cr |
| Net income | -51.45L -44.73L -41.63L -38.22L -72.18L -49Cr -73.3L -4.91Cr -1.93Cr -24Cr -1.93Cr -1.89Cr -82Cr | -28.92L -25.14L -23.4L -21.49L -40.58L -28Cr -41.21L -2.76Cr -1.08Cr -14Cr -1.09Cr -1.06Cr -46Cr |
| Net Debt | 11.45L 10L 9L 9L 16.07L 11Cr 16.32L 1.09Cr 42.88L 5.44Cr 43.02L 42.07L 18Cr | 22.42L 19.49L 18.14L 16.66L 31.46L 21Cr 31.94L 2.14Cr 83.93L 11Cr 84.21L 82.36L 36Cr |
Employees
11
Sector
Pharmaceuticals
- Stock Market
- Stocks
- IPCIQ Stock
- I4AA Stock
Select your edition
All financial news and data tailored to specific country editions
